A Phase 1/2a, Controlled, Randomized, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of StrataGraft Overlay of Meshed Autograft (SOMA) in Treatment of Full-Thickness Thermal Burns
A Phase 1/2a, Controlled, Randomized, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of StrataGraft Overlay of Meshed Autograft (SOMA) in Treatment of Full-Thickness Thermal Burns
Autografting is a surgical procedure to transplant healthy skin (donor skin) from another part of the participant's own body (donor site) to the burned part. Autografting is the usual treatment for full-thickness (FT) burns.
It works to close the wound, but can cause other problems:
Stratatech is trying to find a safe and effective treatment option for severe burns that uses less donor skin.
All participants in this study received meshed autograft on one part of their burn (AG Tx). They received more widely meshed than AG Tx site autograft with a StrataGraft covering (SOMA Tx) on a different part of their burn.
Inclusion Criteria:
Exclusion Criteria:
Is a prisoner, pregnant, or had previous autografting to treatment sites
Is expected to survive less than 3 months
Is participating in another interventional trial, or did within 30 days before enrollment
Has anticipated treatment sites that are outside protocol-specified parameters
Has concurrent clinically significant inhalation injury, inadequate fluid resuscitation, or burns of chemical or electrical (non-thermal) etiology
Has other signs, symptoms or history of any condition that, per protocol or in the opinion of the investigator, might compromise: